Increasing Influenza Vaccination Rates among Patients with Type 2 Diabetes Mellitus in Chongqing, China: A Cross-Sectional Analysis Using Behavioral and Social Drivers Tools-Reference-Cited by-同舟云学术

Increasing Influenza Vaccination Rates among Patients with Type 2 Diabetes Mellitus in Chongqing, China: A Cross-Sectional Analysis Using Behavioral and Social Drivers Tools

Published:2024-08-08 Issue:8 Volume:12 Page:898
ISSN:2076-393X
Container-title:Vaccines
language:en
Short-container-title:Vaccines

Author:

Li Zhourong¹²,Feng Luzhao³,Long Jiang¹⁴,Xiong Yu¹⁴,Li Tingting¹⁴^ORCID,Jiang Binshan³^ORCID,Yang Shuang²,Fu Lin²,Shi Zumin⁵^ORCID,Zhao Yong²^ORCID,Qi Li¹⁴⁶

Affiliation:

1. Chongqing Municipal Center for Disease Control and Prevention, Chongqing 400799, China

2. School of Public Health, Chongqing Medical University, Chongqing 400016, China

3. School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

4. Chongqing Municipal Key Laboratory for High Pathogenic Microbes, Chongqing 400799, China

5. Department of Human Nutrition, College of Health Sciences, QU Health, Qatar University, Doha 2713, Qatar

6. Infectious Disease Control and Prevention, Chongqing Municipal Center for Disease Control and Prevention, Chongqing 400799, China

Abstract

Background: Influenza vaccination is essential for type 2 diabetes mellitus (T2DM) patients due to their higher risks of severe complications and mortality from influenza. This study investigated the willingness of T2DM patients in Chongqing, China, to receive the influenza vaccination during the 2023/2024 season, using behavioral and social drivers (BeSD) tools to improve vaccination uptake in this high-risk group. Methods: A multi-stage sampling method was used to select participants, and face-to-face surveys were conducted in community health centers between March 1 and May 1, 2023. Binary logistic regression was used to analyze the factors influencing vaccination willingness, and standardized scores identified barriers and drivers. Results: Among 1672 T2DM patients, 11.7% had been vaccinated during the 2022/2023 season, and 59.6% were willing to receive the vaccination in the 2023/2024 season. Higher willingness was associated with ethnic minorities (odds ratio [OR], 3.18, 95% confidence interval [CI]: 1.58–6.39), being unemployed individuals (OR 2.69, 95% CI: 1.60–4.52), higher monthly household income per capita (OR 2.72, 95% CI: 1.65–4.50), having diabetes complications (OR 1.76, 95% CI: 1.23–2.51), sufficient vaccine knowledge (OR 1.87, 95% CI: 1.48–2.37), and previous vaccination (OR 7.75, 95% CI: 4.83–12.44). Concerning BeSDs, fear of infecting friends or family members and trust in vaccine efficacy were the predominant drivers, while high vaccine costs were the greatest barrier. Conclusions: Future strategies should focus on improving vaccine knowledge, supporting healthcare workers and peer recommendations, and enhancing vaccination policies. Key interventions such as health education among high-risk groups, such as unemployed individuals, advocacy campaigns, pay-it-forward strategies, and policies for free vaccination could improve coverage in Chongqing.

Funder

Chongqing Science and Technology Bureau

Publisher

MDPI AG

Link

https://www.mdpi.com/2076-393X/12/8/898/pdf

Reference51 articles.

1. Prevalence, treatment patterns and control rates of metabolic syndrome in a Chinese diabetic population: China Cardiometabolic Registries 3B study;Jing;J. Diabetes Investig.,2018

2. Higher frequency of hospitalization but lower relative mortality for pandemic influenza in people with type 2 diabetes;Ruiz;J. Intern. Med.,2020

3. Benefits of flu vaccination for persons with diabetes mellitus: A review;Goeijenbier;Vaccine,2017

4. World Health Organization (2024, March 08). Influenza (Seasonal). Available online: https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal).

5. National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), and Influenza Vaccination TWG (2022). Technical guidelines for seasonal influenza vaccination in China (2022–2023). Zhonghua Liu Xing Bing Xue Za Zhi, 43, 1515–1544.